Establishing a Biobank in Singapore

The Human Biomedical Research Act (HBRA) of Singapore regulates all research that involves human biospecimen in Singapore. Institutions or individuals aiming to establish a biobank under SingHealth must adopt best practices from established biobanks and ISBER. Recently, the team from SingHealth published a poster explaining the “Best Practices for Establishing a Biobank in Singapore Research Institution.” Stages […]

Winship Cancer (Emory University) selects OpenSpecimen as Biobanking LIMS

The Winship Cancer Institute Clinical Trial office (CTO) conducts high-quality clinical trials involving cancer patients. It conducts over 250 clinical trials enrolling roughly 800 patients per year. In May 2016, they adopted OpenSpecimen as their biobanking LIMS to manage their biospecimens due to its highly configurable features including REST APIs to integrate with . Refer to […]

Biobanking as a Newsletter- January’20

Here is your monthly curated pick of biobanking news, jobs, and events from across the globe. Fresh of the Press Australian biobank repatriates hundreds of ‘legacy’ Indigenous blood samples Clinical trials planned for brain tumor ‘GPS’ maps at Case Western Reserve University Geisinger’s biobank surpasses 250,000 patients NIH establishes Infectious Diseases Clinical Research Consortium AI shows promise for breast cancer […]

Is OpenSpecimen CFR Part-11 Compliant?

The short answer is Yes. However, it is important to note that the software itself cannot be compliant. Rather, it is the implementation and use of software that determines compliance. It is achieved only when a study has the procedures, policies, documentation, training, and validation that meets Part-11 requirements. An FDA auditor will review all […]

One Bright Idea!

  I read an article recently about why once in a while “doing nothing” is important and that is why Christmas is my favorite time. Better than Diwali or any of the other 100s of festivals we Indians observe. Simply because you all, my dear customers, will be away. That too, all at the same time! It […]

Managing Longitudinal Collections In OpenSpecimen

Managing biospecimen data for longitudinal studies or clinical trials can be challenging. Clinical studies often go on for months or years, and involves complex workflows like kit preparations, tracking upcoming visits, multi-site collections, shipments, and so forth. To manage these types of collections, OpenSpecimen offers a customizable platform to plan, manage and track biospecimens in a […]

The BBMRI-NL Series on Sustainable Biobanking

The long-term sustainability of biobanks has been a major concern.  “Sustainability is [a biobank’s] capacity to remain operative, effective, and competitive over its expected lifetime.”   OECD Global Science Forum 2017 BBMRI-NL has made a Series on Sustainable Biobanking, combining current knowledge from literature, workshops, and focus groups. The Series contains an infographic with nine recommendations […]